TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.
Dr. Kevin Kalinsky discusses the role of targeted therapy and clinical decision-making in managing estrogen-driven, ...
Immunotherapy advances in triple-negative breast cancer drive personalized treatments with immune checkpoint inhibitors, ...
The article provides strategies for each zodiac sign to combat negative thoughts. From engaging in physical activities and ...
In metastatic triple-negative breast cancer, sacituzumab govitecan was effective and tolerable in the real-world setting.
ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...
“A new era in genetic testing has arrived,” said Carlos Bustamante, Ph.D., CEO & Co-Founder, Galatea Bio. “StrataRisk PRS empowers clinical genetic labs to deliver more informative reports to ...
The term colorectal cancer combines colon and rectal cancer, two parts of the intestine. The first part of the large ...
As genetic and biomarker tests become more common, so do new therapies that target specific tumor types and may lead to ...
Timely receipt of guideline-concordant care can improve survival and may help mitigate racial and ethnic disparities in survival among patients with inflammatory breast cancer, researchers wrote.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback